Reply to Shuting Shi et al., Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity (Vaccine 2019;37 (24):3167-3178)
- PMID: 32145880
- DOI: 10.1016/j.vaccine.2019.11.036
Reply to Shuting Shi et al., Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity (Vaccine 2019;37 (24):3167-3178)
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: GSK funded the costs associated with the development of the present manuscript. Lode Schuerman, corresponding author, is an employee of the GSK group of companies, hold shares in the GSK group of companies and had full access to the data included in the current work and had final responsibility for the decision to submit for publication.
Comment in
-
Response to comment on: Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity.Vaccine. 2020 Mar 17;38(13):2759. doi: 10.1016/j.vaccine.2020.02.016. Vaccine. 2020. PMID: 32145881 No abstract available.
Comment on
-
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity.Vaccine. 2019 May 27;37(24):3167-3178. doi: 10.1016/j.vaccine.2019.04.055. Epub 2019 Apr 29. Vaccine. 2019. PMID: 31047671 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
